Eneda Toska

Has grant

Associate Professor

NYU School of Medicine
Country flagUnited States
ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Recent Grants

Grant: Open

Epigenetic mechanisms of therapy resistance and lineage plasticity in breast cancer

Open Date: 2025-09-01

Close Date: 2029-08-31

Articles (4)

Co-occupied and unique target genes shared between Creb and RNApol-II in chromatin immunoprecipitation and sequencing (ChIP-seq) experiments performed in murine Kras-Trp53 cooperative KPC pancreatic cancer cells

Year:

2025

We have shown that KRAS–TP53 genomic coalteration is associated with immune-excluded microenvironments, chemoresistance, and poor survival in pancreatic ductal adenocarcinoma (PDAC) patients. By treating KRAS – TP53 cooperativity as a model for high-risk biology, we now identify cell-autonomous Cxcl1 as a key mediator of spatial T-cell restriction via interactions with CXCR2 + neutrophilic myeloid-derived suppressor cells in human PDAC using imaging mass cytometry. Silencing of cell-intrinsic Cxcl1 in LSL-Kras G12D/+ ;Trp53 R172H/+ ;Pdx-1 Cre/+ (KPC) cells reprograms the trafficking and functional dynamics of neutrophils to overcome T-cell exclusion and controls tumor growth in a T cell–dependent manner. Mechanistically, neutrophil-derived TNF is a central regulator of this immunologic rewiring, instigating feed-forward Cxcl1 overproduction from tumor cells and cancer-associated fibroblasts (CAF), T-cell dysfunction, and inflammatory CAF polarization via transmembrane TNF–TNFR2 interactions. TNFR2 inhibition disrupts this circuitry and improves sensitivity to chemotherapy in vivo . Our results uncover cancer cell–neutrophil cross-talk in which context-dependent TNF signaling amplifies stromal inflammation and immune tolerance to promote therapeutic resistance in PDAC. Significance: By decoding connections between high-risk tumor genotypes, cell-autonomous inflammatory programs, and myeloid-enriched/T cell–excluded contexts, we identify a novel role for neutrophil-derived TNF in sustaining immunosuppression and stromal inflammation in pancreatic tumor microenvironments. This work offers a conceptual framework by which targeting context-dependent TNF signaling may overcome hallmarks of chemoresistance in pancreatic cancer. This article is highlighted in the In This Issue feature, p. 1275

Year:

2025

Co-occupied and unique target genes shared between Creb and RNApol-II in chromatin immunoprecipitation and sequencing (ChIP-seq) experiments performed in murine Kras-Trp53 cooperative KPC pancreatic cancer cells

Year:

2024

Co-occupied and unique target genes shared between Creb and RNApol-II in chromatin immunoprecipitation and sequencing (ChIP-seq) experiments performed in murine Kras-Trp53 cooperative KPC pancreatic cancer cells

Year:

2024

Collaborators (8)

Ben Stanger

University of Pennsylvania

UNITED STATES
View details

William Hwang

Principal Investigator

Massachusetts General Hospital

UNITED STATES
View details

Nipun B. Merchant

University of Miami Miller School of Medicine

UNITED STATES
View details

Elizabeth Montgomery

Professor of Pathology

University of Miami Hospital

UNITED STATES
View details

Jashodeep Datta

University of Miami

UNITED STATES
View details

Roberta Brambilla

Assistant Professor

University of Miami School of Medicine

UNITED STATES
View details

Alejandro Villarino

Assistant Professor

University of Miami

UNITED STATES
View details

Nagaraj S. Nagathihalli

Associate Professor with Tenure

University of Miami

UNITED STATES
View details